Navigation Links
Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments for Tuberculosis
Date:6/29/2011

PARIS, June 29, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it entered into a research collaboration with Weill Cornell Medical College to develop new anti-infectives that aim to shorten the course of treatment of tuberculosis (TB) and provide effective therapies against drug-susceptible and drug-resistant strains of TB.

(Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO)

Under the terms of the collaboration, Sanofi will provide 80,000 chemical compounds to Dr. Carl Nathan's laboratory at Weill Cornell, where the compounds will be screened to assess their ability to inhibit growth of Mycobacterium tuberculosis. Weill Cornell has secured funding for the screening activities conducted by Dr. Nathan's team from the Bill & Melinda Gates Foundation. Sanofi and Weill Cornell will jointly determine if any compounds screened through the collaboration should be brought forward for optimization and further development.

"Since discovering rifampicin in the early 1960s, Sanofi has continued to pursue new therapeutic approaches to combat TB, including new vaccines and drug candidates with new mechanisms of action," said Elias Zerhouni, President, Global R&D at Sanofi. "This research collaboration with Weill Cornell will enable us to explore the potential of our existing compound library and pool the extensive knowledge of Dr. Nathan and his colleagues with Sanofi's drug development expertise to benefit TB patients worldwide in continuation of our long standing commitment to global health."

Every year, more than 1.7 million people worldwide die from TB. Today's TB drugs are more than 40 years old and must be taken for six to nine months for drug-sensitive disease and up to 24 months for drug-resistant disease. Long, demanding treatment schedules prove too much for many patients and the resulting
'/>"/>

SOURCE Sanofi
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sanofi Pasteur Commends Winners of International BioGENEius Challenge
2. Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen
3. Medco, United BioSource and Sanofi Signed Global Agreement to Improve Quality of Patient Care Through Real-World Evidence
4. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
5. Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims
6. sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
7. Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
8. Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research
9. Sanofi-Aventis Completes Acquisition of Genzyme Corporation
10. Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
11. Navinta LLC is Pleased to Announce US FDA Approval of Sodium Ferric Gluconate Injection in Sucrose [a generic equivalent of Ferrlecit® Injection by Sanofi Aventis] Based on Its Proprietary Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 Zynerba Pharmaceuticals , Inc., a ... transdermal synthetic cannabinoid treatments, today announced that the company ... Conference 2014. The conference will be held December 2 ... New York . Zynerba,s Chairman and CEO, ... on Tuesday, December 2. To listen to ...
(Date:11/26/2014)... Nov. 26, 2014  Aridis Pharmaceuticals, Inc., a ... therapies for infectious diseases, announced today the addition ... recognized key opinion leader in the areas of ... board. Founder and Chief Executive Officer, ... Dr. Opal,s extensive experience investigating bacterial toxins and ...
(Date:11/26/2014)... NEW YORK and ... the leading distributor of market intelligence, MarketResearch.com is pleased ... by IQ4I Research and Consultancy focusing on the active ... about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . ... Ingredients Global Market – Forecast to 2020 ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3
... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... numerous advanced programs from Isis, cardiovascular franchise. The ... Biology,s (ATVB) Annual Conference. The presentations included data ... study of mipomersen in which treatment with mipomersen resulted ...
... CONSHOHOCKEN, Pa., April 30 ePharmaSolutions, a leading provider ... biopharmaceutical industry announced that it has been selected along ... the Bio-IT World Best Practice Award for it,s Clinical ... submissions in 7 categories by a peer reviewed panel ...
Cached Medicine Technology:Isis and Collaborators Present New Research at the ATVB Annual Conference 2Isis and Collaborators Present New Research at the ATVB Annual Conference 3Isis and Collaborators Present New Research at the ATVB Annual Conference 4Isis and Collaborators Present New Research at the ATVB Annual Conference 5ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award 2
(Date:11/27/2014)... 2014 "As a nurse I see ... of urinary incontinence," said an inventor from Whiting, N.J. ... specialized accessory to prevent leakage and keep them dry ... urine leakage. This prevents stains on pants, skirts and ... pad ensures that the individual has time to get ...
(Date:11/27/2014)... THURSDAY, Nov. 27, 2014 (HealthDay News) -- Thanksgiving meals ... eat a gluten-free diet, an expert says. Many ... potatoes and cranberry sauce -- are gluten-free, but "when ... may need to be considered," Dr. Anca Safta, director ... Wake Forest Baptist Medical Center in North Carolina, said ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Tylenol lawsuits ... were allegedly injured by the medication are continuing to ... litigation is looking ahead to a status conference in ... a Scheduling Order issued earlier this year, a conference ... 16th at 10:00 a.m. Items likely to be discussed ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Developers and plugin ... new plugin entitled ProPip, taking FCPX to the next level. ... effect with a few clicks of a mouse,” said Christina ... saver that our users will appreciate.” , With ProPip users ... leaving the possibilities truly endless. ProPip is great for commentaries, ...
(Date:11/27/2014)... to help with chores while they are home from school, ... self-esteem, and above all, helps parents maintain a somewhat tidy ... do you encourage your children to want to help? Is ... Development Journal, there is. The study found that adults’ language ... lend a hand. , The study found that using ...
Breaking Medicine News(10 mins):Health News:Expert Shares Gluten-Free Thanksgiving Tips 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 3
... providers also report a positive financial return on,investment, ... health,information electronically between physicians, hospitals, health plans, and,patients ... outcomes, according,to a new survey released by the ... of Health Information Exchange at the State and,Local ...
... are happy to discuss subject with eye docs, says researcher ... might expect the eye doctor,s office to be the last ... suggests that most people would appreciate such a conversation. ... weekly religious services, and 82 percent felt that prayer was ...
... newly-developed technology at the Delft University of Technology in the ... be a thing of the past. This is the message ... Institute Delft (RID) in an article in university journal ... hospitals are facing a shortage of radio isotopes which means ...
... taking place, experts say , , THURSDAY, Sept. 11 (HealthDay News) -- ... as it is possible to heal at all -- from the ... 2001, experts now say. , "There is a thing called natural ... it takes a long time. What,s happened over the past seven ...
... Secretary of,State George P. Shultz and John B. Shoven, one ... in a free Webinar on,September 29th, 2008 at 1:00 pm ... book "Putting Our House In Order: A Citizen,s Guide,to Social ... entitlement crisis and a unique approach to solving it., ...
... ScentToSleep.com,which specializes in the production and distribution ... the magazine cover "Aromatherapy,secrets that end insomnia!", ... baby?" was researched by Nancy,Minikes. The feature highlights ... tired and wishing they could sleep through the ...
Cached Medicine News:Health News:eHealth Initiative Survey Links Health IT to Lower Costs and Improved Outcomes 2Health News:eHealth Initiative Survey Links Health IT to Lower Costs and Improved Outcomes 3Health News:eHealth Initiative Survey Links Health IT to Lower Costs and Improved Outcomes 4Health News:Spiritual Beliefs Part of Health Care for Some 2Health News:Spiritual Beliefs Part of Health Care for Some 3Health News:Delft University of Technology patent for manufacturing radio isotopes 2Health News:9/11's Psychological Scars Slowly Healing 2Health News:9/11's Psychological Scars Slowly Healing 3Health News:9/11's Psychological Scars Slowly Healing 4Health News:George P. Schultz and John B. Shoven to Speak in Free Webinar on Social Security and Health Care Reform 2Health News:ScentToSleep.com Is Pleased to Announce That the Company Was Featured in the September 15th Issue of Woman's World Magazine 2
McPherson titanium tying forceps which is 5 mm long, smooth jaws and straight. Used for 8-0 to 11-0 sutures....
Straight shafts with 5 mm tying platform. Wide handle with dull finish. Overall length 4.3 inches....
Delicate curved tying forcep with round handle is excellent for all fine suturing techniques. Useful for corneal transplants where delicate control is required....
Angled Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Medicine Products: